These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 20025704)

  • 1. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.
    Arenal A; Proclemer A; Kloppe A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Europace; 2016 Nov; 18(11):1719-1725. PubMed ID: 27485577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mean entropy calculated from cardiac MRI texture analysis is associated with antitachycardia pacing failure.
    Gould J; Porter B; Sidhu BS; Claridge S; Chen Z; Sieniewicz BJ; Elliott M; Mehta V; Campos FO; Bishop MJ; Costa CM; Niederer S; Ganeshan B; Razavi R; Chiribiri A; Rinaldi CA
    Pacing Clin Electrophysiol; 2020 Jul; 43(7):737-745. PubMed ID: 32469085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal programming management of ventricular tachycardia storm in ICD patients.
    Qian Z; Guo J; Zhang Z; Wang Y; Hou X; Zou J
    J Biomed Res; 2015 Jan; 29(1):35-43. PubMed ID: 25745473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of anti-tachycardia pacing efficacy through scar-specific delivery and minimization of re-initiation: a virtual study on a cohort of infarcted porcine hearts.
    Qian S; Connolly A; Mendonca-Costa C; Campos F; Rodero C; Whitaker J; Rinaldi CA; Bishop MJ
    Europace; 2023 Feb; 25(2):716-725. PubMed ID: 36197749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in ventricular tachyarrythmias and antitachycardia pacing effectiveness according to the ICD indication (primary versus secondary prevention): an analysis based on the stored electrograms.
    Jiménez-Candil J; Hernández J; Martín A; Moríñigo J; Perdiguero P; Bravo L; Ruiz S; Sánchez PL
    J Interv Card Electrophysiol; 2015 Nov; 44(2):187-95. PubMed ID: 26306456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia is predicted by sum absolute QRST integralbut not by QRS width.
    Tereshchenko LG; Cheng A; Fetics BJ; Marine JE; Spragg DD; Sinha S; Calkins H; Tomaselli GF; Berger RD
    J Electrocardiol; 2010; 43(6):548-52. PubMed ID: 20832820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragmentation of the paced QRS complex: a marker of antitachycardia pacing effectiveness among ICD patients.
    Jiménez-Candil J; Moríñigo JL; Hernández J; Martín A; Durán O; Carlos Rama J; Ledesma C; Sánchez PL
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1100-8. PubMed ID: 24816219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE; Sweeney MO; Wathen MS; Josephson ME; Otterness MF; Hogan-Miller E; Stark AJ; Degroot PJ;
    J Am Coll Cardiol; 2005 Jul; 46(2):310-6. PubMed ID: 16022960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients.
    Jiménez-Candil J; Hernández J; Martín A; Moríñigo J; López R; Ledesma C; Martín-Luengo C
    Heart Rhythm; 2013 Feb; 10(2):207-13. PubMed ID: 23085131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients.
    Arenal A; Ortiz M; Peinado R; Merino JL; Quesada A; Atienza F; Alberola AG; Ormaetxe J; Castellanos E; Rodriguez JC; Pérez N; García J; Boluda L; del Prado M; Artés A
    Heart Rhythm; 2007 Mar; 4(3):316-22. PubMed ID: 17341396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients.
    Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the duration of the basal QRS complex and electrical therapies for ventricular tachycardias among ICD patients.
    Jiménez-Candil J; Ruiz M; Herrero J; León V; Martín A; Moriñigo J; Ledesma C; Martín-Luengo C
    Pacing Clin Electrophysiol; 2010 May; 33(5):596-604. PubMed ID: 20025704
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.